Rebecca Margaret Therriault, MS, CF-SLP | |
30 Warren Street, Brighton, MA 02135 | |
(617) 254-3800 | |
Not Available |
Full Name | Rebecca Margaret Therriault |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 30 Warren Street, Brighton, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386893329 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Rebecca Margaret Therriault, MS, CF-SLP 111 Jersey Street, Apt. 21b, Boston, MA 02215 Ph: (518) 669-2139 | Rebecca Margaret Therriault, MS, CF-SLP 30 Warren Street, Brighton, MA 02135 Ph: (617) 254-3800 |
News Archive
Gene therapies developed by University of Pennsylvania School of Veterinary Medicine researchers have worked to correct different forms of blindness. While effective, the downside to these approaches to vision rescue is that each disease requires its own form of gene therapy to correct the particular genetic mutation involved, a time consuming and complex process.
University of Alabama at Birmingham researchers have been awarded a three-year contract with a total potential amount of $10 million to study the efficacy of the vaccine Bexsero - already licensed to prevent meningitis - in protecting vulnerable populations from infection with the bacteria that causes gonorrhea.
BrainStorm Cell Therapeutics Inc., an innovative developer of adult stem cell technologies and Central Nervous System (CNS) therapeutics, today announced that it completed a registered public offering of 19,818,972 shares of common stock at a price per share of $0.29 and warrants to purchase 14,864,229 shares of common stock at an exercise price of $0.29 per share, representing gross proceeds of $5,747,502.
Bio-Images Research and Medimetrics Personalized Drug Delivery have today announced a partnership to introduce the IntelliCap to the global pharmaceutical industry as a clinical research tool. The announcement was made at the annual meeting of the American Association of Pharmaceutical Scientists, being held in Washington DC, USA, between 23 and 27 October 2011.
› Verified 4 days ago
Ms. Margaret Arcuni Huber, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 617-562-7735 | |
Sara Elizabeth Gardner, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 242 Corey Rd, Brighton, MA 02135 Phone: 203-241-1926 | |
Julia Martine Rifkin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 Warren St, Brighton, MA 02135 Phone: 617-254-3800 | |
Viktoriya Berdichevsky, M.S., SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 Warren St, Brighton, MA 02135 Phone: 617-254-3800 | |
Mrs. Svetlana Piliavsky, MED-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 170 Corey Rd, Brighton, MA 02135 Phone: 617-383-6624 | |
Mrs. Aliza Zissel Schwab, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19 Portina Rd, Brighton, MA 02135 Phone: 516-640-0882 | |
Jennifer S Bartecchi, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 Warren St, Brighton, MA 02135 Phone: 617-779-1626 |